Predictive Potential of BCS and Pharmacokinetic Parameters on Study Outcome: Analysis of 198 In Vivo Bioequivalence Studies.

Krajcar, Dejan; Grabnar, Iztok; Jereb, Rebeka; Legen, Igor; Opara, Jerneja

Krajcar, Dejan; Grabnar, Iztok; Jereb, Rebeka; Legen, Igor; Opara, Jerneja.

Afiliação

Krajcar D; Lek Pharmaceuticals d.d., A Sandoz Company, Verovskova 57, 1526, Ljubljana, Slovenia. dejan.krajcar@sandoz.com.
Grabnar I; Faculty of Pharmacy, University of Ljubljana, Askerceva cesta 7, 1000, Ljubljana, Slovenia. dejan.krajcar@sandoz.com.
Jereb R; Faculty of Pharmacy, University of Ljubljana, Askerceva cesta 7, 1000, Ljubljana, Slovenia.
Legen I; Lek Pharmaceuticals d.d., A Sandoz Company, Verovskova 57, 1526, Ljubljana, Slovenia.
Opara J; Lek Pharmaceuticals d.d., A Sandoz Company, Verovskova 57, 1526, Ljubljana, Slovenia.

Eur J Drug Metab Pharmacokinet ; 48(3): 241-255, 2023 May.

Article em En | MEDLINE | ID: mdl-36872388

Assuntos

Biofarmácia; Biofarmácia/métodos; Equivalência Terapêutica; Estudos Retrospectivos; Solubilidade; Disponibilidade Biológica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biofarmácia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google